Trademark: 78862931
Word
PALVATA
Status
Dead
Status Code
606
Status Date
Monday, March 7, 2011
Serial Number
78862931
Mark Type
4000
Filing Date
Monday, April 17, 2006
Published for Opposition
Tuesday, November 13, 2007
Abandoned Date
Monday, March 7, 2011

Trademark Owner History

Classifications
5 Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan

Trademark Events
Jan 22, 2014
Attorney Revoked And/Or Appointed
Jan 22, 2014
Teas Revoke/Appoint Attorney Received
Mar 23, 2011
Assignment Of Ownership Not Updated Automatically
Mar 7, 2011
Abandonment Notice Mailed - No Use Statement Filed
Mar 7, 2011
Abandonment - No Use Statement Filed
Oct 13, 2010
Assignment Of Ownership Not Updated Automatically
Aug 7, 2010
Notice Of Approval Of Extension Request E-Mailed
Aug 6, 2010
Extension 5 Granted
Aug 3, 2010
Extension 5 Filed
Aug 3, 2010
Teas Extension Received
Feb 8, 2010
Extension 4 Granted
Feb 3, 2010
Extension 4 Filed
Feb 3, 2010
Teas Extension Received
Jul 31, 2009
Extension 3 Granted
Jul 30, 2009
Extension 3 Filed
Jul 30, 2009
Teas Extension Received
Jun 17, 2009
Assignment Of Ownership Not Updated Automatically
Feb 18, 2009
Extension 2 Granted
Feb 4, 2009
Extension 2 Filed
Feb 17, 2009
Case Assigned To Intent To Use Paralegal
Feb 4, 2009
Teas Extension Received
Jan 22, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 22, 2009
Teas Change Of Owner Address Received
Aug 4, 2008
Extension 1 Granted
Aug 4, 2008
Extension 1 Filed
Aug 4, 2008
Teas Extension Received
Feb 5, 2008
Noa Mailed - Sou Required From Applicant
Nov 23, 2007
Changes/Corrections After Pub Approval Entered
Nov 20, 2007
Assigned To Petition Staff
Nov 15, 2007
Fax Received
Nov 13, 2007
Published For Opposition
Oct 24, 2007
Notice Of Publication
Oct 10, 2007
Law Office Publication Review Completed
Oct 10, 2007
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 10, 2007
Assigned To Lie
Sep 29, 2007
Teas Change Of Correspondence Received
Sep 10, 2007
Approved For Pub - Principal Register
Sep 6, 2007
Teas Change Of Correspondence Received
Sep 6, 2007
Teas/Email Correspondence Entered
Sep 6, 2007
Correspondence Received In Law Office
Sep 6, 2007
Teas Response To Office Action Received
Mar 15, 2007
Final Refusal E-Mailed
Mar 15, 2007
Final Refusal Written
Mar 14, 2007
Teas/Email Correspondence Entered
Mar 13, 2007
Correspondence Received In Law Office
Mar 13, 2007
Teas Response To Office Action Received
Sep 13, 2006
Non-Final Action E-Mailed
Sep 13, 2006
Non-Final Action Written
Sep 13, 2006
Assigned To Examiner
Apr 21, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24